TFO
MRNA icon

Tarbox Family Office’s Moderna MRNA Stock Holding History

Tarbox Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-108
Closed -$19K – 653
2022
Q1 		$19K Buy
108
+65
+151% +$10.9K ﹤0.01% 293
2021
Q4 		$11K Sell
43
-121
-74% -$35.4K ﹤0.01% 443
2021
Q3 		$63K Buy
164
+131
+397% +$48.3K 0.01% 214
2021
Q2 		$8K Buy
33
+14
+74% +$2.5K ﹤0.01% 529
2021
Q1 		$2K Sell
19
-50
-72% -$7.25K ﹤0.01% 904
2020
Q4 		$7K Buy
69
+50
+263% +$5.06K ﹤0.01% 461
2020
Q3 		$1K Hold
19
– – ﹤0.01% 1009
2020
Q2 		$1K Hold
19
– – ﹤0.01% 1008
2020
Q1 		$1K Buy
+19
New +$437 ﹤0.01% 918

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tarbox Family Office's MRNA Position: Q2 2022 in Review

Tarbox Family Office sold out of Moderna (MRNA) in Q2 2022, closing a stake of 108 shares — an estimated $19K sold.

Tarbox Family Office first reported a position in MRNA in Q1 2020 and held it in 9 quarters. The position peaked at $63K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Tarbox Family Office reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 108 Moderna shares in Q2 2022, an estimated $19K.
  • Tarbox Family Office first reported a position in Moderna in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Moderna position peaked at $63K in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.